Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 7, 2014 - Issue
Submit an article Journal homepage
139
Views
10
CrossRef citations to date
0
Altmetric
Review

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Zeid Kayali1 Division of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA, USA
&
Warren N Schmidt2 Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Iowa City, IA, USA;3 Roy G and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USACorrespondence[email protected]
Pages 387-398 | Published online: 08 Dec 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Katherine Hu, Zhaowen Zhu, Meleah M Mathahs, Huy Tran, Jerry Bommer, Charles A Testa & Warren N Schmidt. (2020) Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships. Drug Design, Development and Therapy 14, pages 757-771.
Read now
Ivan Gentile, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo & Guglielmo Borgia. (2015) The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C. Expert Opinion on Drug Discovery 10:12, pages 1363-1377.
Read now

Articles from other publishers (8)

Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco MazzoranaMaria P. Costi & Michele Tonelli. (2023) Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective. Journal of Medicinal Chemistry 66:6, pages 3664-3702.
Crossref
F M Hanif, Z Majid, N H Luck, A A Tasneem, S M Laeeq & M Mubarak. (2022) Revolution in the diagnosis and management of hepatitis C virus infection in current era. World Journal of Hepatology 14:4, pages 647-669.
Crossref
Mona Seifert, Subhas C Bera, Pauline van Nies, Robert N Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, Xiangzhi Meng, Hongjie Xia, James M Wood, Lawrence D Harris, Flavia S Papini, Jamie J Arnold, Steven Almo, Tyler L Grove, Pei-Yong Shi, Yan Xiang, Bruno Canard, Martin Depken, Craig E Cameron & David Dulin. (2021) Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. eLife 10.
Crossref
Saima Ali Haider, Bashir Ahmad, Sajid Ali, Ali Haider, Shumaila Bashir & Nourin Mahmood. (2020) Sofosbuvir and Ribavirin Combination Therapy Response in Various Hepatitis C Virus Genotypes in Peshawar, Khyber Pakhtunkhwa. Jundishapur Journal of Microbiology 13:6.
Crossref
Dongrong Yi, Quanjie Li, Lili Pang, Yujia Wang, Yongxin Zhang, Zhaojun Duan, Chen Liang & Shan Cen. (2020) Identification of a Broad-Spectrum Viral Inhibitor Targeting a Novel Allosteric Site in the RNA-Dependent RNA Polymerases of Dengue Virus and Norovirus. Frontiers in Microbiology 11.
Crossref
Elena Campione, Annunziata Dattola, Monia Di Prete, Daniele Di Paolo, Amedeo Ferlosio, Augusto Orlandi & Luca Bianchi. (2019) Sofosbuvir induced leucocytoclasic vasculitis: a case report. BMC Dermatology 19:1.
Crossref
Yue Feng, Yue-Mei Feng, Yang Feng, Caixia Lu, Li Liu, Xiaomei Sun, Jiejie Dai & Xueshan Xia. (2015) Identification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing. Hepatitis Monthly 15:10.
Crossref
Yuan Liu, Ziying Zou, Bing Zhu, Zonghai Hu, Ping Zeng & Lijuan Wu. (2015) LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes. Hepatitis Monthly 15:5.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.